Orphan Indications In Medicare: Inspector General Will Examine Top-Selling Drugs

OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.

PS1807_Pills Under Scrutiny_141058420_1200.jpg
Review Prompted By Spike In Orphan Approvals

More from Rare Diseases

More from Pink Sheet